Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immunotherapy

Below is an extended Immunotherapy patents listing. Click here to return to the Immunotherapy main in depth entry.

Patents :

US Patent No.Title
7612064 Sulfopyrroles
7615207 Methods for treating irritable bowel syndrome
7615208 Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging
7615214 Anti-human VEGF receptor Flt-1 monoclonal antibody
7615215 Anti-human VEGF receptor Flt-1 monoclonal antibody
7615223 Selected immunoconjugates for binding to aminophospholipids
7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
7615227 Use of CpG oligodeoxynucleotides to induce angiogenesis
7615349 Melanoma gene signature
7615359 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
7615379 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
7613491 Silicone based membranes for use in implantable glucose sensors
7612226 Amino acid derivatives
7612182 Anti-IL-6 antibodies, compositions, methods and uses
7612077 Crystalline forms of the anti-cancer compound ZD1839
7612091 Caspase inhibitors and uses thereof
7612162 Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
7612169 Osteoprotegerin variant proteins
7612170 Co-stimulatory polypeptides
7612172 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
7612178 Anti-IGF-1R antibodies and uses thereof
7612179 antibodies binding to a C-terminal fragment of apoliopoprotein E
7612180 Humanized L243 antibodies
7612181 Dual variable domain immunoglobulin and uses thereof
7615539 Nucleic acid-lipophilic conjugates
7615612 Polypeptide
7618817 Genetically modified human natural killer cell lines
7618944 Encapsulated amyloid-beta peptides
7618948 Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
7618968 Aryl triazines as LPAAT-.beta. inhibitors and uses thereof
7618983 Bicyclic triazole .alpha.4 integrin inhibitors
7619000 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer
7619057 MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
7619058 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
7619063 Chimeric immunogens
7619067 Evolved interferon-alpha polypeptides
7618791 Methods of detecting cancer with antibodies to cytokine receptor ZCYTOR19
7618790 Method for NGF assay for in vitro diagnosis of breast cancer and therapeutic use
7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
7615643 Benzimidazole thiophene compounds
7618626 Combination treatment for non-hematologic malignancies
7618628 CD16A binding proteins and use for the treatment of immune disorders
7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
7618632 Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
7618634 Neurotoxic oligomers
7618635 Super-antigen fusion proteins and the use thereof
7618637 Heat shock protein-based vaccines and immunotherapies
7618655 Method for the preparation of aqueous solutions of reactive chlorine compounds
7619068 Ovr110 antibody compositions and methods of use

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.